Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_assertion type Assertion NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_head.
- NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_assertion description "[We studied nine patients affected by chronic myeloid leukemia (CML Ph+ and bcr-abl positive) and treated with alpha-interferon (alpha-INF) in order to: first, to evaluate the feasibility of a mobilization of peripheral blood stem cells induced by granulocyte-colony-stimulating factor (G-CSF) and the contamination by Ph+ cells and second, to quantify the amount of bcr-abl leukemia associated transcript by a quantitative assay during mobilization procedures, and post mobilization follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_provenance.
- NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_assertion evidence source_evidence_literature NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_provenance.
- NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_assertion SIO_000772 10975389 NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_provenance.
- NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_assertion wasDerivedFrom befree-20150227 NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_provenance.
- NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_assertion wasGeneratedBy ECO_0000203 NP331728.RAnnmq_UcJ7KbAvCT2pstR_dVL2C6HBMo5mGywz_2Gh3g130_provenance.